NDRA News and Press, ENDRA Life Sciences Inc.

2023-05-09 12:13:32 ET Cancer test makers iCAD ( NASDAQ: ICAD ) and Hologic ( NASDAQ: HOLX ) recorded sharp gains on Tuesday after the U.S. Preventive Services Task Force issued draft changes to breast cancer screening guidelines. Per the proposed guidelines, the task ...

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today announced that the company will report financial results for the three months ended March 31, 2023 on Monday, May 15, 2023 after the close of trading on the U.S. financia...

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced today the closing of its previously announced underwritten public offering of 4,312,500 shares of its common stock and ...

2023-04-28 10:28:43 ET ENDRA Life Sciences ( NASDAQ: NDRA ) has priced a public offering of 3.75 million shares and warrants to purchase 1.875 million shares, the company said on Friday. Net proceeds from the offering is expected to be $3.9 million after deducting discounts an...

2023-04-28 08:33:44 ET Hillstream BioPharma ( HILS ) -57% on pricing $2.65M equity offering . Centogene ( CNTG ) -26% receives Nasdaq non-compliance notice . Cloudflare ( NET ) -25% after Q1 earnings release . Snap ( SNAP ) -18% afte...

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced today that it has priced an underwritten public offering of 3,750,000 shares of its common stock and warrants to purcha...

2023-03-13 17:35:55 ET Major earnings expected after the bell on Tuesday include: Skillz ( SKLZ ) SentinelOne ( S ) StoneCo Ltd. ( STNE ) Lennar Corporation ( LEN ) Smartsheet ( SMAR ) For further details see: Notable earnings after Tuesda...

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today announced that the company will report financial results for the three months and year ended December 31, 2022 on Tuesday, March 14, 2023 after the close of trading on th...

ENDRA Life Sciences Inc. (NASDAQ: NDRA) (the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced today that it will be effecting a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20. The reverse stock ...

ENDRA Life Sciences Inc. (NDRA) Q3 2022 Earnings Conference Call November 14, 2022 04:30 PM ET Company Participants Yvonne Briggs - Investor Relations Francois Michelon - Chairman & Chief Executive Officer Michael Thornton - Chief Technology Officer Renau...